These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 15477483

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chemoreduction for retinoblastoma.
    Moll AC, Imhof SM, Schouten-van Meeteren AY, Boers M, van Leeuwen F, Hofman P.
    Arch Ophthalmol; 2003 Oct; 121(10):1513. PubMed ID: 14557204
    [No Abstract] [Full Text] [Related]

  • 3. Chemoreduction for retinoblastoma may prevent intracranial neuroblastic malignancy (trilateral retinoblastoma).
    Shields CL, Meadows AT, Shields JA, Carvalho C, Smith AF.
    Arch Ophthalmol; 2001 Sep; 119(9):1269-72. PubMed ID: 11545631
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Chemoreduction for retinoblastoma may prevent trilateral retinoblastoma.
    Shields CL, Shields JA, Meadows AT.
    J Clin Oncol; 2000 Jan; 18(1):236-7. PubMed ID: 10623718
    [No Abstract] [Full Text] [Related]

  • 10. From a Suspicious Cystic Pineal Gland to Pineoblastoma in a Patient with Familial Unilateral Retinoblastoma.
    de Jong MC, Moll AC, Göricke S, van der Valk P, Kors WA, Castelijns JA, de Graaf P.
    Ophthalmic Genet; 2016 Jan; 37(1):116-8. PubMed ID: 24940935
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 16. Restoration of foveal anatomy and function following chemoreduction for bilateral advanced retinoblastoma with total retinal detachment.
    Shields CL, Materin MA, Shields JA.
    Arch Ophthalmol; 2005 Nov; 123(11):1610-2. PubMed ID: 16286630
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.